20 August 2026 Guidelines Inflammatory Arthritis Pain New UK pain guideline puts brakes on long-term analgesics
20 August 2026 Clinical research Pharmaceuticals Psoriatic Athritis Sonelokimab clears phase 3 PsA hurdle
20 August 2026 Biologics Clinical research Psoriatic Athritis Oral TYK2 inhibitor holds PsA gains to one year
20 August 2026 Clinical research Rheumatoid Arthritis Bispecific T-cell engager may ‘reset’ drug resistance in refractory RA
20 August 2026 Clinical research Public Health Rheumatoid Arthritis Air pollution linked to RA flares
6 August 2026 Fibromyalgia Genetics Strongest evidence yet that fibromyalgia is rooted in nervous system biology
23 July 2026 Clinical research DMARDS Rheumatoid Arthritis Cochrane backs Australian approach to RA evidence
9 July 2026 Clinical research Sjogren Syndrom Interferon signal strengthens case for precision medicine in Sjögren’s disease
9 July 2026 ANCA-associated vasculitis FDA Pharmaceuticals Avacopan trial retracted as regulators diverge
9 July 2026 ANCA-associated vasculitis Pharmaceuticals CSL issues open letter as EU moves to revoke avacopan approval
9 July 2026 Clinical research Obesity Psoriatic Athritis Higher BMI may blunt TNF inhibitor response in PsA
9 July 2026 Interstitial Lung Disease Pharmaceuticals Rheumatoid Arthritis Methotrexate comes out best in RA-ILD analysis
